CollPlant Biotechnologies (CLGN) Other Operating Expenses (2018 - 2020)

CollPlant Biotechnologies' Other Operating Expenses history runs 3 years deep, the most recent figure standing at $5.8 billion for Q4 2020.

• Quarterly Other Operating Expenses changed N/A year-over-year to $5.8 billion in Q4 2020, while the trailing twelve-month figure through Sep 2021 was $5.8 billion (up 394.07% YoY) and the FY2020 annual result came in at -$228000.0, up 6.17% from the prior year.
• Other Operating Expenses was $5.8 billion for Q4 2020 at CollPlant Biotechnologies, up from -$2.0 billion in the prior quarter.
• Across five years, Other Operating Expenses topped out at $5.8 billion in Q4 2020 and bottomed at -$2.0 billion in Q3 2020.
• A 3-year average of $546.4 million and a median of -$163000.0 in 2019 frame the typical range for Other Operating Expenses.
• Peak annual rise in Other Operating Expenses reached 336.36% in 2019, while the deepest fall reached 336.36% in 2019.
• CollPlant Biotechnologies' Other Operating Expenses stood at -$290000.0 in 2018, then soared by 43.79% to -$163000.0 in 2019, then soared by 3556049.69% to $5.8 billion in 2020.
• Business Quant data shows CLGN's Other Operating Expenses at $5.8 billion in Q4 2020, -$2.0 billion in Q3 2020, and -$163000.0 in Q2 2019.